New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling Pathways
用于分析酪氨酸激酶信号通路的蛋白质组学新技术
基本信息
- 批准号:8325721
- 负责人:
- 金额:$ 34.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityBiochemicalBiological ModelsBreast Cancer CellCancer BiologyCell ProliferationCellsCharacteristicsChemicalsClinical DataComplex MixturesCoupledDataDevelopmentDiseaseEventGoalsGrowthImmuneIndividualKnowledgeLeadLinkMalignant NeoplasmsMapsMass Spectrum AnalysisMedicineMethodologyMethodsModelingModificationMolecularMonitorNeoplasm MetastasisOutcomePathway interactionsPhosphopeptidesPhosphoproteinsPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPlayPolymersPropertyProtein Tyrosine KinaseProteinsProteomicsProtocols documentationResearchResearch PersonnelRoleSeriesSignal PathwaySignal TransductionSiteSquamous cell carcinomaSystemTechniquesTechnologyTestingTherapeuticTumor Suppressor ProteinsTyrosine PhosphorylationTyrosine Phosphorylation Sitebasecancer cellcancer preventioncancer typecell growthcell growth regulationcell motilitycell typedesignhuman SYK proteinimprovedin vivoinnovationinterestleukemia/lymphomamalignant breast neoplasmmalignant phenotypemelanomaneoplastic cellnoveloutcome forecastoverexpressionpre-clinicalpublic health relevanceresponsetool
项目摘要
DESCRIPTION (provided by applicant): A key objective of phosphoproteomic analyses is to obtain an in-depth understanding of protein phosphorylation and signaling networks in cells. However, despite the great progress that has been made over the past few years, our ability to analyze such signaling pathways is still greatly limited by a number of serious technical challenges. The long term goal is to develop novel proteomics strategies valuable for understanding on the molecular level the role of phosphorylation in regulating cell proliferation. The objective in this application is to devise and optimize effective and efficient methodologies and strategies for the analyses of tyrosine kinase phosphoproteomes, using a dual functional tyrosine kinase Syk as the model system. This approach will utilize functional, soluble polymers for the efficient and inclusive isolation of phosphopeptides coupled with an integrated chemical, mass spectrometric, and computational strategy for the identification of specific tyrosine kinase substrates and for quantitative phosphoproteomics. We will focus on Syk-dependent signaling and establish protocols that will ultimately provide a powerful method to dissect any signaling pathway regulated by protein-tyrosine phosphorylation. Guided by strong preliminary data, this objective will be achieved by pursuing three specific aims: 1) Develop a proteomic platform for the analysis of protein phosphorylation. We will primarily develop, characterize and optimize functionalized soluble polymers designed for the affinity and chemical isolation of phosphopeptides; 2) Identification of specific tyrosine-kinase substrates and their phosphorylation sites; and 3) In-depth analyses of tyrosine kinase phosphoproteomes in several cancer types. We will develop and apply our quantitative proteomic technologies for the identification and quantification of tyrosine-phosphorylation sites in several cancer types. This project is innovative because it will develop a series of novel analytical techniques to directly identify novel tyrosine kinase substrates and phosphorylation sites that will provide investigators with a significantly expanded capability to dissect signaling pathways. The developed techniques will provide detailed knowledge at the molecular level on precisely how tyrosine kinases are involved in cell signaling under different physiological conditions through dynamic changes in protein phosphorylation. It is also expected that, by identifying a kinase's direct substrates, the proposed research will provide a powerful tool to conveniently map kinase networks.
PUBLIC HEALTH RELEVANCE: The proposed studies to develop a series of analytical techniques have potential applicability for investigators in the molecular signaling field. The tools will allow them to examine important roles of tyrosine kinase in multiple signaling pathways. The proposed research will provide unique strategies and materials that will strengthen the important contribution that proteomics can make to our understanding of cancer biology.
描述(由申请人提供):磷酸化蛋白质组学分析的一个关键目标是深入了解细胞中的蛋白质磷酸化和信号网络。然而,尽管在过去几年中取得了很大的进展,但我们分析这些信号通路的能力仍然受到许多严重技术挑战的极大限制。长期目标是开发新的蛋白质组学策略,在分子水平上理解磷酸化在调节细胞增殖中的作用。本申请的目的是设计和优化有效和高效的方法和策略,用于分析酪氨酸激酶磷酸化蛋白质组,使用双功能酪氨酸激酶Syk作为模型系统。这种方法将利用功能性的可溶性聚合物,用于磷酸肽的有效和包容性分离,并结合集成的化学,质谱和计算策略,用于识别特定的酪氨酸激酶底物和定量磷酸蛋白质组学。我们将专注于Syk依赖的信号转导和建立协议,最终将提供一个强大的方法来剖析任何由蛋白质酪氨酸磷酸化调节的信号通路。在强大的初步数据的指导下,这一目标将通过追求三个具体目标来实现:1)开发一个蛋白质组学平台,用于分析蛋白质磷酸化。我们将主要开发,表征和优化功能化可溶性聚合物,用于磷酸肽的亲和和化学分离; 2)识别特定的酪氨酸激酶底物及其磷酸化位点; 3)深入分析几种癌症类型中的酪氨酸激酶磷酸化蛋白质组。我们将开发和应用我们的定量蛋白质组学技术,用于识别和定量几种癌症类型中的酪氨酸磷酸化位点。该项目是创新的,因为它将开发一系列新的分析技术,以直接识别新的酪氨酸激酶底物和磷酸化位点,这将为研究人员提供一个显着扩展的能力,剖析信号通路。开发的技术将提供详细的知识,在分子水平上,正是如何酪氨酸激酶参与细胞信号在不同的生理条件下,通过蛋白质磷酸化的动态变化。我们还希望,通过识别激酶的直接底物,所提出的研究将提供一个强大的工具,方便地映射激酶网络。
公共卫生相关性:所提出的研究,以开发一系列的分析技术具有潜在的适用性,研究人员在分子信号领域。这些工具将使他们能够研究酪氨酸激酶在多种信号通路中的重要作用。这项研究将提供独特的策略和材料,加强蛋白质组学对我们理解癌症生物学的重要贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W. Andy Tao其他文献
Epitope Imprinting of Phospholipids by Oriented Assembly at Oil/Water Interface for the Selective Recognition of Plasma Membranes
- DOI:
10.1002/anie.202213938 - 发表时间:
2023 - 期刊:
- 影响因子:
- 作者:
Juntao Zhou;Xianhui Cheng;Zhanchen Guo;Muhammad Mujahid Ali;Guiyuan Zhang;W. Andy Tao;Lianghai Hu;Zhen Liu - 通讯作者:
Zhen Liu
Mass spectrometry-based phosphoproteomics in clinical applications
基于质谱的临床应用磷酸化蛋白质组学
- DOI:
10.1016/j.trac.2023.117066 - 发表时间:
2023-06-01 - 期刊:
- 影响因子:12.000
- 作者:
Xiaofeng Wu;Yi-Kai Liu;Anton B. Iliuk;W. Andy Tao - 通讯作者:
W. Andy Tao
High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array
基于化学探针阵列的细胞外囊泡高通量捕获与原位蛋白分析
- DOI:
10.1038/s41596-024-01082-z - 发表时间:
2024-10-22 - 期刊:
- 影响因子:16.000
- 作者:
Xin Feng;Ao Shen;Wei Zhang;Shengnan Jia;Anton Iliuk;Yuling Wang;Wenke Zhang;Ying Zhang;W. Andy Tao;Lianghai Hu - 通讯作者:
Lianghai Hu
Playing tag with quantitative proteomics
- DOI:
10.1007/s00216-008-2386-0 - 发表时间:
2008-10-10 - 期刊:
- 影响因子:3.800
- 作者:
Anton Iliuk;Jacob Galan;W. Andy Tao - 通讯作者:
W. Andy Tao
W. Andy Tao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W. Andy Tao', 18)}}的其他基金
Developing high throughput measurement of thiopurine in DNA by mass spectrometry
通过质谱法开发 DNA 中硫嘌呤的高通量测量
- 批准号:
9909135 - 财政年份:2020
- 资助金额:
$ 34.49万 - 项目类别:
Developing EV surface proteins as biosignatures for Alzheimer's disease (AD)
开发 EV 表面蛋白作为阿尔茨海默病 (AD) 的生物特征
- 批准号:
9908966 - 财政年份:2020
- 资助金额:
$ 34.49万 - 项目类别:
Dissecting signaling pathways and seeking EV phosphoproteins as novel biomarkers for Alzheimer's Disease
剖析信号通路并寻找 EV 磷蛋白作为阿尔茨海默病的新型生物标志物
- 批准号:
10399815 - 财政年份:2020
- 资助金额:
$ 34.49万 - 项目类别:
Developing novel RPPA for the detection of metastatic prostate cancer
开发新型 RPPA 用于检测转移性前列腺癌
- 批准号:
9200292 - 财政年份:2016
- 资助金额:
$ 34.49万 - 项目类别:
A Proteomic Platform to identify and Validate Biomarkers in Metabolic Syndrome and Coronary Artery Disease
用于识别和验证代谢综合征和冠状动脉疾病生物标志物的蛋白质组学平台
- 批准号:
9325547 - 财政年份:2015
- 资助金额:
$ 34.49万 - 项目类别:
A Proteomic Platform to identify and Validate Biomarkers in Metabolic Syndrome and Coronary Artery Disease
用于识别和验证代谢综合征和冠状动脉疾病生物标志物的蛋白质组学平台
- 批准号:
9144821 - 财政年份:2015
- 资助金额:
$ 34.49万 - 项目类别:
A Proteomic Platform to identify and Validate Biomarkers in Metabolic Syndrome and Coronary Artery Disease
用于识别和验证代谢综合征和冠状动脉疾病生物标志物的蛋白质组学平台
- 批准号:
8887497 - 财政年份:2015
- 资助金额:
$ 34.49万 - 项目类别:
Proteomic differentiation of leukemia cells based on multiplexed arrays and mass
基于多重阵列和质量的白血病细胞的蛋白质组分化
- 批准号:
8451922 - 财政年份:2013
- 资助金额:
$ 34.49万 - 项目类别:
New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling Pathways
用于分析酪氨酸激酶信号通路的蛋白质组学新技术
- 批准号:
8537209 - 财政年份:2010
- 资助金额:
$ 34.49万 - 项目类别:
New Proteomic Technologies for the Analysis of Tyrosine Kinase Signaling Pathways
用于分析酪氨酸激酶信号通路的蛋白质组学新技术
- 批准号:
7986538 - 财政年份:2010
- 资助金额:
$ 34.49万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 34.49万 - 项目类别:
Continuing Grant
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Standard Grant
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Operating Grants
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
- 批准号:
22KJ2600 - 财政年份:2023
- 资助金额:
$ 34.49万 - 项目类别:
Grant-in-Aid for JSPS Fellows